Close Menu

Friday Frontiers in Biomedical Science

Dec
09
4:00 pm to 5:00 pm
Friday Frontiers logo

Friday Frontiers in Biomedical Science is designed to engage researchers and clinicians at all stages of career development. This session features University of Arizona College of Medicine – Tucson associate professor of immunobiology, Michael D. L. Johnson, PhD, and associate professor of pediatrics, Daniel J. Moore, MD, PhD from Vanderbilt University. The two speakers will share a 20-minute overview of their work, with an opportunity for audience engagement. Light refreshments will be provided. 

Photo of Dr. Michael D. L. Johnson
Michael D. L. Johnson, PhD
Associate Professor, Immunobiology and BIO5 Institute
University of Arizona College of Medicine – Tucson

Title: Exploiting antimicrobial properties of copper as a therapeutic

Dr. Johnson in an associate professor of immunobiology, member of the UArizona BIO5 Institute and director of the National Summer Undergraduate Research Project. Dr. Johnson's research investigates the role of metals as cofactors or structural components that compose roughly 40% of all proteins. His laboratory investigates how bacteria maintain homeostasis within the metal milieu. Dr. Johnson's research also determines how metals are processed, the orchestrated response during metal sensing and the role that the host plays in this process during infection. Understanding how bacteria interact with metals during infections will identify novel therapeutic strategies against bacterial infections.

Photo of Dr. Daniel Moore
Daniel J. Moore, MD, PhD
Associate Professor of Pediatrics, Pathology, Microbiology and Immunology
Vanderbilt University

Title: Insights into the pathogenesis and prediction of Type 1 diabetes progression

Dr. Moore is an associate professor of pediatrics and the director of the Fellowship in Pediatric Endocrinology at Vanderbilt University. Dr. Moore's research seeks to understand the cellular and molecular mechanisms that govern immune tolerance in order to prevent and reverse Type 1 diabetes and enhance the success of organ transplantation. This research formed part of the foundation for current efforts to use B cell directed therapies to prevent diabetes, studies in which Vanderbilt is participating through the Type 1 diabetes TrialNet where Dr. Moore is a co-investigator. He is presently extending these studies to understand how B lymphocytes control immune tolerance to transplants and how this cell type participates in broken tolerance in autoimmune disease such as Type 1 diabetes.

To request any disability-related accommodations for this event please contact the event coordinator at least three business days prior to the event.
Dec
09
4:00 pm to 5:00 pm
Friday, December 9, 2022 - 4:00pm
Add to Calendar

AUDIENCE

Faculty, Staff, Students
College of Medicine – Tucson

LOCATION

Tucson area
Virtual
Health Sciences – Tucson
University of Arizona Cancer Center
Kiewit Auditorium
1515 N. Campbell Ave., Tucson AZ 85724

CONTACT

Loren Drake
College of Medicine – Tucson